Lexaria Bioscience Correlations

LEXX Stock

USD 1.90 0.08 4.04%

The current 90-days correlation between Lexaria Bioscience Corp and Immix Biopharma is 0.04 (i.e., Significant diversification). The correlation of Lexaria Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Lexaria Bioscience Correlation With Market

Average diversification

The correlation between Lexaria Bioscience Corp and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lexaria Bioscience Corp and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Moving together with Lexaria Stock

0.81	AZN	AstraZeneca PLC ADR	Pair Corr
0.83	GSK	GlaxoSmithKline PLC ADR	Pair Corr
0.8	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.74	NVS	Novartis AG ADR	Pair Corr
0.64	PFE	Pfizer Inc Earnings Call This Week	Pair Corr
0.63	SNY	Sanofi ADR	Pair Corr
0.66	BIAF	bioAffinity Technologies,	Pair Corr
0.77	BIIB	Biogen Inc	Pair Corr
0.61	BKRKF	PT Bank Rakyat	Pair Corr
0.72	BKRKY	Bank Rakyat Normal Trading	Pair Corr
0.7	PPERY	Bank Mandiri Persero Earnings Call This Week	Pair Corr
0.63	PPERF	Bank Mandiri Persero Earnings Call This Week	Pair Corr
0.73	PBCRY	Bank Central Asia Earnings Call This Week	Pair Corr
0.73	PTBRY	Bank Negara Indonesia Earnings Call This Week	Pair Corr

Moving against Lexaria Stock

0.64	LH	Laboratory	Pair Corr
0.49	GILD	Gilead Sciences	Pair Corr
0.46	MBFJF	Mitsubishi UFJ Financial	Pair Corr
0.68	EXEEW	Expand Energy Symbol Change	Pair Corr
0.67	OPFI	OppFi Inc Buyout Trend	Pair Corr
0.67	JPM	JPMorgan Chase	Pair Corr
0.56	CSCO	Cisco Systems Aggressive Push	Pair Corr
0.48	WMT	Walmart	Pair Corr
0.45	MZHOF	Mizuho Financial	Pair Corr
0.33	T	ATT Inc Earnings Call Today	Pair Corr

Related Correlations Analysis

	REVB	ZURA	PHIO	ZVSA	RNAZ	IMMX	CNSP	EFTR	NAVB	SONN
REVB		0.82	0.23	0.52	0.78	-0.78	0.58	0.27	0.52	0.76	REVB
ZURA	0.82		0.25	0.71	0.91	-0.75	0.58	0.36	0.72	0.9	ZURA
PHIO	0.23	0.25		0.34	0.33	-0.26	0.13	0.07	0.27	0.3	PHIO
ZVSA	0.52	0.71	0.34		0.76	-0.64	0.51	0.46	0.91	0.85	ZVSA
RNAZ	0.78	0.91	0.33	0.76		-0.81	0.56	0.56	0.8	0.95	RNAZ
IMMX	-0.78	-0.75	-0.26	-0.64	-0.81		-0.51	-0.46	-0.63	-0.78	IMMX
CNSP	0.58	0.58	0.13	0.51	0.56	-0.51		0.12	0.59	0.66	CNSP
EFTR	0.27	0.36	0.07	0.46	0.56	-0.46	0.12		0.57	0.48	EFTR
NAVB	0.52	0.72	0.27	0.91	0.8	-0.63	0.59	0.57		0.9	NAVB
SONN	0.76	0.9	0.3	0.85	0.95	-0.78	0.66	0.48	0.9		SONN
	REVB	ZURA	PHIO	ZVSA	RNAZ	IMMX	CNSP	EFTR	NAVB	SONN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SONN	+ 0.95	RNAZ
RNAZ	+ 0.91	ZURA
NAVB	+ 0.91	ZVSA
SONN	+ 0.9	ZURA
SONN	+ 0.9	NAVB
SONN	+ 0.85	ZVSA

High negative correlations

IMMX	- 0.81	RNAZ
SONN	- 0.78	IMMX
IMMX	- 0.78	REVB
IMMX	- 0.75	ZURA
IMMX	- 0.64	ZVSA
NAVB	- 0.63	IMMX

Risk-Adjusted Indicators

There is a big difference between Lexaria Stock performing well and Lexaria Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lexaria Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
REVB	5.84	(0.49)	0.00	(0.30)	0.00	0.00	17.95	(8.82)	73.15
ZURA	4.55	(1.05)	0.00	1.13	0.00	0.00	9.21	(11.55)	26.70
PHIO	11.71	2.69	0.23	0.74	10.57	(16.85)	12.33	(18.46)	336.29
ZVSA	5.27	(0.33)	0.00	(0.08)	0.00	0.00	13.76	(8.06)	78.93
RNAZ	5.66	(2.58)	0.00	(1.81)	0.00	0.00	10.33	(11.78)	51.05
IMMX	4.71	0.79	0.14	(1.25)	4.68	(5.78)	11.44	(8.19)	33.17
CNSP	4.26	(0.04)	0.00	0.08	0.00	0.00	10.00	(9.09)	39.29
EFTR	7.57	(4.57)	0.00	(35.84)	0.00	0.00	8.70	(27.78)	88.91
NAVB	6.04	(1.04)	0.00	0.42	0.00	0.00	12.50	(12.50)	40.40
SONN	4.73	(1.49)	0.00	12.56	0.00	0.00	9.38	(12.92)	37.58

Lexaria Bioscience Corporate Management

Christopher Bunka	Chairman CEO	Profile
Vanessa Carle	Head Legal	Profile
Philip Ainslie	Advisor Consultant	Profile
Nelson CPA	Chief Officer	Profile
CPA CMA	Chief Officer	Profile
Richard Christopher	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC